Literature DB >> 15075785

Tumour spectrum of non-polyposis colorectal cancer (Lynch syndrome) on the island of Tenerife and influence of insularity on the clinical manifestations.

V Medina-Arana1, Y Barrios, A Fernández-Peralta, A Jiménez, E Salido, F González, J J González-Aguilera.   

Abstract

Colorectal cancer is a complex disease from a genetic point of view because both genetic and environmental factors interact in its development. Only familial adenomatous polyposis (FAP) follows mendelian genetics, in that mutations of the APC gene lead to development of the tumours. Lynch syndrome is the most frequent form of hereditary colorectal cancer and appears to be associated with other types of extracolonic cancers. The genetic basis has been established as a defect in DNA mismatch repair genes, and there is genetic heterogeneity due to the involvement of several genes in this system. Germinal mutations in these genes predispose to appearance of the syndrome. The aim of this study is to describe the tumoral spectrum of 10 families, comprising a total of 488 individuals, from the island of Tenerife (Canary Islands) and to assess whether the geographical isolation of this population has changed any features of the tumoral spectrum of the syndrome in comparison with studies that cover larger geographical areas with more genetic exchange. From our results we can conclude that the genetic drift and consanguinity in this population with a demographic history of isolation did not significantly alter the tumoral spectrum of the syndrome. Our data confirm that families affected by Lynch syndrome are a high-risk population and should be closely monitored, since their careful supervision has been shown to be useful in preventing cancer. We also emphasize the importance of developing a complete family history that permits these families to be identified together with a mutational screening of DNA mismatch repair genes (mainly MLH1 and MSH2 genes) with the aim of a possible identification of members of a family that should be carefully monitored (the carriers of germline mutations in these genes), whereas the remaining members, originally, are no more at risk than the general population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075785     DOI: 10.1097/00008469-200402000-00005

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  4 in total

1.  The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.

Authors:  Juana V Martín-López; Ysamar Barrios; Vicente Medina-Arana; Miguel Andújar; Sanghee Lee; Liya Gu; Guo-Min Li; Josef Rüschoff; Eduardo Salido; Richard Fishel
Journal:  Carcinogenesis       Date:  2012-06-27       Impact factor: 4.944

2.  Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome.

Authors:  V Medina-Arana; L Delgado; L González; A Bravo; H Díaz; E Salido; D Riverol; J J González-Aguilera; A M Fernández-Peralta
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

3.  Strategy for mapping quantitative trait loci (QTL) by using human metapopulations.

Authors:  Igor Rudan; Zrinka Biloglav; Andrew D Carothers; Alan F Wright; Harry Campbell
Journal:  Croat Med J       Date:  2006-08       Impact factor: 1.351

4.  Hereditary nonpolyposis colorectal cancer and familial colorectal cancer in Central part of Iran, Isfahan.

Authors:  Amin Nemati; Zahra Kazemi Rahmatabadi; Alimohammad Fatemi; Mohammad Hassan Emami
Journal:  J Res Med Sci       Date:  2012-01       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.